Determination of Advanced Oxidation Protein Products, E3 SUMO-Protein Ligase NSE2[NSMCE2], as a Marker to Predict Child Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is a cancer of the blood and bone marrow (spongy tissue in the center of bone). In ALL, too many bone marrow stem cells develop into a type of white blood cell called lymphocytes. These abnormal lymphocytes are not able to fight infection very well. The aim of this...
Saved in:
| Main Author: | Baghdad Science Journal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Baghdad, College of Science for Women
2014-03-01
|
| Series: | مجلة بغداد للعلوم |
| Subjects: | |
| Online Access: | http://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/1543 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation between malondialdehyde and metanephrine in patients with acute lymphoblastic leukemia
by: Baghdad Science Journal
Published: (2014-09-01) -
6-mercaptopurine Metabolites as Predictors of Neutropenia and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia
by: Ebrahim Salehifar, et al.
Published: (2025-01-01) -
Immunophenotypic investigation of infant acute lymphoblastic leukemia
by: A. M. Popov, et al.
Published: (2014-07-01) -
COVID-19 in patients with acute lymphoblastic leukemia
by: T. S. Chudnova, et al.
Published: (2024-09-01) -
Chemotherapy‐Induced Peripheral Polyneuropathy in Pediatric Acute Lymphoblastic Leukemia: A Case Report on Manifestation, Management, and Outcome
by: Eman Al Mattar, et al.
Published: (2025-08-01)